2-butyl-3-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
AlkaPlorer ID: AK089837
Synonym: None
IUPAC Name: 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Structure
SMILES: CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1
InChI: InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)
InChIKey: YOSHYTLCDANDAN-UHFFFAOYSA-N
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Rhus chinensis | Rhus | Anacardiaceae | Sapindales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
Properties Information
Molecule Weight: 428.5400000000001
TPSA?: 87.13000000000001
MolLogP?: 4.777400000000004
Number of H-Donors: 1
Number of H-Acceptors: 5
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | 6.33 | % | 10.6019/CHEMBL4513141 |
| Bos taurus | Progesterone receptor | IC50 | nan | None | None |
| Bos taurus | Progesterone receptor | Ki | nan | None | None |
| Candida albicans | Candida albicans | Inhibition | -0.2 | % | 10.6019/CHEMBL4513141 |
| Cavia porcellus | Leukotriene C4 synthase | IC50 | nan | None | None |
| Cavia porcellus | Leukotriene C4 synthase | Ki | nan | None | None |
| Cavia porcellus | Serotonin 4 (5-HT4) receptor | IC50 | nan | None | None |
| Cavia porcellus | Serotonin 4 (5-HT4) receptor | Ki | nan | None | None |
| Cercopithecidae | Monkey | Delta MAP | 9.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Cercopithecidae | Monkey | Delta MAP | 15.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Cercopithecidae | Monkey | Delta MAP | 18.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Cercopithecidae | Monkey | Delta MAP | 23.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Cercopithecidae | Monkey | Delta MAP | 25.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Cercopithecidae | Monkey | Delta MAP | 33.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Chlorocebus aethiops | COS-7 | Activity | nan | None | 10.1016/j.ejmech.2020.112258 |
| Cryptococcus neoformans | Cryptococcus neoformans | Inhibition | 0.28 | % | 10.6019/CHEMBL4513141 |
| Danio rerio | Danio rerio | Activity | 15.0 | % | 10.1021/acs.jnatprod.9b00857 |
| Danio rerio | Danio rerio | Activity | 25.0 | % | 10.1021/acs.jnatprod.9b00857 |
| Danio rerio | Danio rerio | Activity | 30.0 | % | 10.1021/acs.jnatprod.9b00857 |
| Danio rerio | Danio rerio | Activity | 36.0 | % | 10.1021/acs.jnatprod.9b00857 |
| Escherichia coli | Escherichia coli | Inhibition | -3.35 | % | 10.6019/CHEMBL4513141 |
| Hepatitis B virus | Hepatitis B virus | IC50 | 3300.0 | nM | 10.1021/acs.jmedchem.6b01442 |
| Hepatitis delta virus | Hepatitis delta virus | EC50 | 9400.0 | nM | 10.1021/acs.jmedchem.2c01097 |
| Homo sapiens | Acetylcholinesterase | IC50 | nan | None | None |
| Homo sapiens | Acetylcholinesterase | Ki | nan | None | None |
| Homo sapiens | Adenosine A1 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A1 receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A1 receptor | Ki | nan | None | None |
| Homo sapiens | Adenosine A2a receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A2a receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A2a receptor | Ki | nan | None | None |
| Homo sapiens | Adenosine A3 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A3 receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A3 receptor | Ki | nan | None | None |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Inhib (Mean) | -34.59 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Inhib (Mean) | -32.35 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Inhib (Mean) | -19.59 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Inhib (Mean) | 6.75 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Max (Mean) | 13.92 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-1d adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-1d adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-2a adrenergic receptor | %Inhib (Mean) | -48.3 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | %Inhib (Mean) | -34.75 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | %Inhib (Mean) | -24.13 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | %Inhib (Mean) | -16.29 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Alpha-2a adrenergic receptor | %Max (Mean) | 5.4 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2b adrenergic receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2b adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-2b adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Alpha-2c adrenergic receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2c adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-2c adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Angiotensin II receptor | IC50 | 3.0 | nM | 10.1021/jm9904147 |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | AC50 | 95999.7 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | AC50 | 100000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | IC50 | nan | None | None |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | Ki | nan | None | None |
| Homo sapiens | Apelin receptor | %Inhib (Mean) | -39.32 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Apelin receptor | %Inhib (Mean) | 7.31 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Apelin receptor | %Inhib (Mean) | 14.97 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Apelin receptor | %Inhib (Mean) | 24.37 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Apelin receptor | %Max (Mean) | 1.332 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-1 adrenergic receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Beta-1 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-1 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Beta-2 adrenergic receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Beta-2 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-2 adrenergic receptor | %Inhib (Mean) | -39.12 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-2 adrenergic receptor | %Inhib (Mean) | -23.1 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-2 adrenergic receptor | %Inhib (Mean) | 0.53 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-2 adrenergic receptor | %Inhib (Mean) | 18.34 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-2 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Beta-2 adrenergic receptor | %Max (Mean) | -1.9 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-3 adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Beta-3 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-3 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Bile acid transporter | IC50 | 30000.0 | nM | 10.1016/j.bmcl.2019.126623 |
| Homo sapiens | Bile acid transporter | Ki | 11900.0 | nM | 10.1021/acs.jmedchem.2c01097 |
| Homo sapiens | Bile salt export pump | IC50 | 7300.0 | nM | 10.1021/acs.jmedchem.0c00524 |
| Homo sapiens | Bile salt export pump | IC50 | 7310.0 | nM | 10.1002/hep.27206 |
| Homo sapiens | Bile salt export pump | IC50 | 7310.0 | nM | 10.1093/toxsci/kft176 |
| Homo sapiens | Bradykinin B1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Bradykinin B2 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Bradykinin B2 receptor | IC50 | nan | None | None |
| Homo sapiens | Bradykinin B2 receptor | Ki | nan | None | None |
| Homo sapiens | Bromodomain-containing protein 4 | Delta TM | -3.71 | C | None |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Inhib (Mean) | -79.34 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Inhib (Mean) | -6.02 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Inhib (Mean) | -5.76 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Inhib (Mean) | -2.67 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Max (Mean) | -3.984 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Caco-2 | Activity | 100.0 | nm/s | 10.1021/jm049548x |
| Homo sapiens | Calcitonin receptor | IC50 | nan | None | None |
| Homo sapiens | Calcitonin receptor | Ki | nan | None | None |
| Homo sapiens | Canalicular multispecific organic anion transporter 1 | Activity | nan | None | 10.1093/toxsci/kft176 |
| Homo sapiens | Canalicular multispecific organic anion transporter 2 | IC50 | 21100.0 | nM | 10.1093/toxsci/kft176 |
| Homo sapiens | Cannabinoid CB1 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cannabinoid CB1 receptor | IC50 | nan | None | None |
| Homo sapiens | Cannabinoid CB1 receptor | Ki | nan | None | None |
| Homo sapiens | Carbonic anhydrase II | IC50 | nan | None | None |
| Homo sapiens | Carbonic anhydrase II | Ki | nan | None | None |
| Homo sapiens | Casein kinase I delta | Delta TM | 0.34 | C | None |
| Homo sapiens | Caspase-1 | IC50 | nan | None | None |
| Homo sapiens | Caspase-1 | Ki | nan | None | None |
| Homo sapiens | Cathepsin G | IC50 | nan | None | None |
| Homo sapiens | Cathepsin G | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 2 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 2 | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 4 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 4 | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 5 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 5 | Ki | nan | None | None |
| Homo sapiens | Cholecystokinin A receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cholecystokinin A receptor | IC50 | nan | None | None |
| Homo sapiens | Cholecystokinin A receptor | Ki | nan | None | None |
| Homo sapiens | Cholecystokinin B receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Corticotropin releasing factor receptor 1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Corticotropin releasing factor receptor 2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Inhib (Mean) | -55.24 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Inhib (Mean) | -26.16 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Inhib (Mean) | -23.57 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Inhib (Mean) | -13.1 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Max (Mean) | 1.405 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Cyclin-dependent kinase 2 | Delta TM | 0.15 | C | None |
| Homo sapiens | Cyclooxygenase-1 | IC50 | nan | None | None |
| Homo sapiens | Cyclooxygenase-1 | Ki | nan | None | None |
| Homo sapiens | Cyclooxygenase-2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cyclooxygenase-2 | IC50 | nan | None | None |
| Homo sapiens | Cyclooxygenase-2 | Ki | nan | None | None |
| Homo sapiens | Cysteinyl leukotriene receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Cysteinyl leukotriene receptor 1 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 1A2 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 1A2 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2A6 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2A6 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | Activity | nan | None | 10.1124/dmd.110.037259 |
| Homo sapiens | Cytochrome P450 2C9 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2E1 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2E1 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | Potency | 15848.9 | nM | None |
| Homo sapiens | Delta opioid receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Delta opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Delta opioid receptor | Ki | nan | None | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 100.0 | nM | None |
| Homo sapiens | Dopamine D1 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D1 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D1 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D2 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D2 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D2 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D3 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D3 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D3 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D4 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D4 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D4 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D5 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine transporter | IC50 | nan | None | None |
| Homo sapiens | Dopamine transporter | Ki | nan | None | None |
| Homo sapiens | Endothelin receptor ET-A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Endothelin receptor ET-A | IC50 | nan | None | None |
| Homo sapiens | Endothelin receptor ET-A | Ki | 0.0001 | nM | 10.1021/jm020138n |
| Homo sapiens | Endothelin receptor ET-A | Ki | 10000.0 | nM | 10.1021/jm058225d |
| Homo sapiens | Endothelin receptor ET-A | Ki | 10000.0 | nM | 10.1021/jm300682j |
| Homo sapiens | Endothelin receptor ET-A | Ki | nan | None | None |
| Homo sapiens | Endothelin receptor ET-B | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Epidermal growth factor receptor erbB1 | IC50 | nan | None | None |
| Homo sapiens | Epidermal growth factor receptor erbB1 | Ki | nan | None | None |
| Homo sapiens | Equilibrative nucleoside transporter 1 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor alpha | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor alpha | IC50 | nan | None | None |
| Homo sapiens | Estrogen receptor alpha | Ki | nan | None | None |
| Homo sapiens | Estrogen receptor beta | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor beta | IC50 | nan | None | None |
| Homo sapiens | Estrogen receptor beta | Ki | nan | None | None |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 53.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 54.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 14985.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15057.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15078.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15171.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16285.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16485.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16657.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 17835.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Growth Rate | -0.32 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | -0.26 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.01 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.09 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.38 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.58 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.66 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.98 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 48.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 49.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 57.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 44.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 52.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 54.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 92.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 98.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 99.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 53.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 117.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 125.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 129.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 141.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 148.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 150.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 151.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 155.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 159.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 170.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 173.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 176.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 178.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 183.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 187.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 197.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast growth factor receptor 3 | Delta TM | 0.21 | C | None |
| Homo sapiens | GABA-B receptor 1 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Gastric inhibitory polypeptide receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Ghrelin receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Inhib (Mean) | -47.11 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Inhib (Mean) | -22.44 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Inhib (Mean) | -19.84 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Inhib (Mean) | -19.31 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Max (Mean) | 1.55 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Glucocorticoid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Glucocorticoid receptor | IC50 | nan | None | None |
| Homo sapiens | Glucocorticoid receptor | Ki | nan | None | None |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Inhib (Mean) | -19.64 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Inhib (Mean) | -16.33 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Inhib (Mean) | -16.13 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Inhib (Mean) | -12.31 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Max (Mean) | 1.074 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glycogen synthase kinase-3 beta | Delta TM | -0.07 | C | None |
| Homo sapiens | G-protein coupled receptor 120 | %Inhib (Mean) | -113.5 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 120 | %Inhib (Mean) | -80.29 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 120 | %Inhib (Mean) | -21.87 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 120 | %Inhib (Mean) | -21.55 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 120 | %Max (Mean) | -0.6 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 35 | %Inhib (Mean) | -25.39 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 35 | %Max (Mean) | 16.13 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | HASMC | IC50 | 320.0 | nM | 10.1021/jm9504722 |
| Homo sapiens | HCT-116 | Activity | 88.0 | % | 10.1021/acsmedchemlett.1c00240 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 82.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Membrane Permeable-Phenotype Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Membrane Permeable-Phenotype Cells (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 22878.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 29842.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 35035.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 45150.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 45535.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 60692.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 68271.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 101135.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Growth Rate | 0.31 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.68 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.8 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.86 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 27.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 70.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 78.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 84.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 49.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 64.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 53.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 70.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 86.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 89.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 90.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 91.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 92.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 95.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 98.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 166.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 219.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 242.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 245.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 287.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 351.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 352.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 353.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 434.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 456.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 473.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 500.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 625.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 684.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 705.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 958.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Hepatocyte | CL | 3.85 | mL.min-1.kg-1 | 10.1016/j.ejmech.2008.07.027 |
| Homo sapiens | Hepatocyte | logCL | 0.5855 | None | 10.1016/j.ejmech.2008.07.027 |
| Homo sapiens | HERG | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | HERG | IC50 | 194984.46 | nM | 10.1016/j.ejmech.2010.11.042 |
| Homo sapiens | HERG | IC50 | nan | None | None |
| Homo sapiens | HERG | Ki | nan | None | None |
| Homo sapiens | Histamine H1 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histamine H1 receptor | IC50 | nan | None | None |
| Homo sapiens | Histamine H1 receptor | Ki | nan | None | None |
| Homo sapiens | Histamine H2 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histamine H2 receptor | IC50 | nan | None | None |
| Homo sapiens | Histamine H2 receptor | Ki | nan | None | None |
| Homo sapiens | Histamine H3 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -8.81 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -1.24 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HMG-CoA reductase | IC50 | nan | None | None |
| Homo sapiens | HMG-CoA reductase | Ki | nan | None | None |
| Homo sapiens | Homo sapiens | Activity | nan | None | 10.1002/hep.27206 |
| Homo sapiens | Homo sapiens | AUC | 22656.91 | ng.hr.mL-1 | 10.1093/toxsci/kft176 |
| Homo sapiens | Homo sapiens | CL | 2.12 | mL.min-1.kg-1 | None |
| Homo sapiens | Homo sapiens | Cmax | 3033.56 | nM | None |
| Homo sapiens | Homo sapiens | Cmax | 3505.0 | nM | 10.1002/hep.27206 |
| Homo sapiens | Homo sapiens | Css | 2.203 | uM | 10.1093/toxsci/kft176 |
| Homo sapiens | Homo sapiens | DILI_Concern | nan | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Homo sapiens | DILI_severity_class | 5.0 | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Homo sapiens | Excretion | 2.2 | % | None |
| Homo sapiens | Homo sapiens | F | 60.0 | % | None |
| Homo sapiens | Homo sapiens | F | 70.0 | % | 10.1016/j.bmc.2007.08.060 |
| Homo sapiens | Homo sapiens | T1/2 | 13.0 | hr | None |
| Homo sapiens | Homo sapiens | Tmax | 1.2 | hr | None |
| Homo sapiens | Homo sapiens | Vd | 2.9 | L.kg-1 | None |
| Homo sapiens | Interleukin-8 receptor A | IC50 | nan | None | None |
| Homo sapiens | Interleukin-8 receptor A | Ki | nan | None | None |
| Homo sapiens | Interleukin-8 receptor B | IC50 | nan | None | None |
| Homo sapiens | Interleukin-8 receptor B | Ki | nan | None | None |
| Homo sapiens | Kappa opioid receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Kappa opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Kappa opioid receptor | Ki | nan | None | None |
| Homo sapiens | Leukocyte common antigen | IC50 | nan | None | None |
| Homo sapiens | Leukocyte common antigen | Ki | nan | None | None |
| Homo sapiens | Leukocyte elastase | IC50 | nan | None | None |
| Homo sapiens | Leukocyte elastase | Ki | nan | None | None |
| Homo sapiens | Leukotriene B4 receptor 1 | Activity | nan | None | 10.1021/acsmedchemlett.1c00240 |
| Homo sapiens | Leukotriene B4 receptor 2 | EC50 | 410.0 | nM | 10.1021/acsmedchemlett.1c00240 |
| Homo sapiens | Leukotriene B4 receptor 2 | Efficacy | 69.0 | % | 10.1021/acsmedchemlett.1c00240 |
| Homo sapiens | Lipoxin A4 receptor | %Inhib (Mean) | -62.94 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lipoxin A4 receptor | %Inhib (Mean) | -20.77 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lipoxin A4 receptor | %Inhib (Mean) | -11.48 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lipoxin A4 receptor | %Inhib (Mean) | -2.54 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lipoxin A4 receptor | %Max (Mean) | -2.87 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lysosomal alpha-glucosidase | Potency | 446.7 | nM | None |
| Homo sapiens | MAP kinase ERK1 | IC50 | nan | None | None |
| Homo sapiens | MAP kinase ERK1 | Ki | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Delta TM | 0.2 | C | None |
| Homo sapiens | MAP kinase ERK2 | IC50 | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Ki | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Potency | 19952.6 | nM | None |
| Homo sapiens | MAP kinase p38 alpha | IC50 | nan | None | None |
| Homo sapiens | MAP kinase p38 alpha | Ki | nan | None | None |
| Homo sapiens | Matrix metalloproteinase-1 | IC50 | nan | None | None |
| Homo sapiens | Matrix metalloproteinase-1 | Ki | nan | None | None |
| Homo sapiens | Matrix metalloproteinase 9 | IC50 | nan | None | None |
| Homo sapiens | Matrix metalloproteinase 9 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 3 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Melanocortin receptor 3 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 3 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 4 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Melanocortin receptor 4 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 4 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 5 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 5 | Ki | nan | None | None |
| Homo sapiens | microRNA 21 | Potency | 6561.4 | nM | None |
| Homo sapiens | Monoamine oxidase A | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Monoamine oxidase A | IC50 | nan | None | None |
| Homo sapiens | Monoamine oxidase A | Ki | nan | None | None |
| Homo sapiens | Motilin receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Multidrug and toxin extrusion protein 1 | IC50 | 500000.0 | nM | 10.1021/jm301302s |
| Homo sapiens | Multidrug and toxin extrusion protein 1 | Inhibition | 15.0 | % | 10.1021/jm301302s |
| Homo sapiens | Multidrug resistance-associated protein 4 | IC50 | 83200.0 | nM | 10.1093/toxsci/kft176 |
| Homo sapiens | Mu opioid receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Mu opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Mu opioid receptor | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | Ki | nan | None | None |
| Homo sapiens | Neurokinin 1 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Neurokinin 1 receptor | IC50 | nan | None | None |
| Homo sapiens | Neurokinin 1 receptor | Ki | nan | None | None |
| Homo sapiens | Neurokinin 2 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Neurokinin 2 receptor | IC50 | nan | None | None |
| Homo sapiens | Neurokinin 2 receptor | Ki | nan | None | None |
| Homo sapiens | Neuronal acetylcholine receptor protein alpha-4 subunit | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Neuropeptide Y receptor type 1 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Neuropeptide Y receptor type 1 | IC50 | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 1 | Ki | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Neuropeptide Y receptor type 2 | IC50 | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 2 | Ki | nan | None | None |
| Homo sapiens | Neurotensin receptor 1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Norepinephrine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Norepinephrine transporter | IC50 | nan | None | None |
| Homo sapiens | Norepinephrine transporter | Ki | nan | None | None |
| Homo sapiens | Peregrin | Delta TM | -3.84 | C | None |
| Homo sapiens | Peroxisome proliferator-activated receptor gamma | Alpha max | 8.1 | % | 10.1016/j.ejmech.2020.112258 |
| Homo sapiens | Peroxisome proliferator-activated receptor gamma | EC50 | nan | None | 10.1016/j.ejmech.2020.112258 |
| Homo sapiens | Phosphodiesterase 3A | AC50 | 4098.8 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 4D | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 5A | IC50 | nan | None | None |
| Homo sapiens | Phosphodiesterase 5A | Ki | nan | None | None |
| Homo sapiens | Phosphodiesterase 6A | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Plasma | PPB | 98.0 | % | 10.1016/j.bmcl.2011.04.133 |
| Homo sapiens | Platelet activating factor receptor | IC50 | nan | None | None |
| Homo sapiens | Platelet activating factor receptor | Ki | nan | None | None |
| Homo sapiens | Prelamin-A/C | Potency | 398.1 | nM | None |
| Homo sapiens | Progesterone receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Protein kinase C alpha | IC50 | nan | None | None |
| Homo sapiens | Protein kinase C alpha | Ki | nan | None | None |
| Homo sapiens | Receptor protein-tyrosine kinase erbB-2 | IC50 | nan | None | None |
| Homo sapiens | Receptor protein-tyrosine kinase erbB-2 | Ki | nan | None | None |
| Homo sapiens | Serine/threonine-protein kinase Aurora-A | Delta TM | 0.12 | C | None |
| Homo sapiens | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform | IC50 | nan | None | None |
| Homo sapiens | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform | Ki | nan | None | None |
| Homo sapiens | Serotonin 1a (5-HT1a) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | AC50 | 35000.2 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 3a (5-HT3a) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 5a (5-HT5a) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 7 (5-HT7) receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin transporter | IC50 | nan | None | None |
| Homo sapiens | Serotonin transporter | Ki | nan | None | None |
| Homo sapiens | Sigma opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Sigma opioid receptor | Ki | nan | None | None |
| Homo sapiens | Solute carrier organic anion transporter family member 1B1 | Inhibition | 76.05 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Solute carrier organic anion transporter family member 1B3 | Inhibition | 47.18 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Inhib (Mean) | -15.3 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Inhib (Mean) | -8.92 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Inhib (Mean) | -8.13 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Inhib (Mean) | -1.53 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Max (Mean) | -0.5207 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Thromboxane A2 receptor | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Thromboxane A2 receptor | Inhibition | 50.0 | % | 10.1021/acs.jmedchem.0c00262 |
| Homo sapiens | Thromboxane A2 receptor | MEC | 0.5 | uM | 10.1021/acs.jmedchem.0c00262 |
| Homo sapiens | Thromboxane-A synthase | IC50 | nan | None | None |
| Homo sapiens | Thromboxane-A synthase | Ki | nan | None | None |
| Homo sapiens | Transcription intermediary factor 1-alpha | Delta TM | -3.66 | C | None |
| Homo sapiens | Type-1 angiotensin II receptor | AC50 | 0.8 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Type-1 angiotensin II receptor | AC50 | 0.9 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Type-1 angiotensin II receptor | AC50 | 1.7 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Type-1 angiotensin II receptor | Affinity | 1.3 | nM | 10.1021/jm049024x |
| Homo sapiens | Type-1 angiotensin II receptor | AT1 affinity | 1.3 | nM l-1 | 10.1021/jm0204237 |
| Homo sapiens | Type-1 angiotensin II receptor | Emax | 2.5 | hr | 10.1021/jm049024x |
| Homo sapiens | Type-1 angiotensin II receptor | IC50 | 6.0 | nM | 10.1021/acsmedchemlett.1c00240 |
| Homo sapiens | Type-1 angiotensin II receptor | IC50 | 20.8 | nM | 10.1016/j.bmc.2010.10.043 |
| Homo sapiens | Type-1 angiotensin II receptor | %Inhib (Mean) | 90.39 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | %Inhib (Mean) | 96.87 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | %Inhib (Mean) | 100.24 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | %Inhib (Mean) | 103.02 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | K | 0.039 | /min | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | K | 0.04 | /min | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | K | 0.058 | /min | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | K | 0.101 | /min | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | K | 0.104 | /min | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | K | 0.128 | /min | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | Ki | 0.8 | nM | 10.1021/jm058225d |
| Homo sapiens | Type-1 angiotensin II receptor | Ki | 0.8 | nM | 10.1021/jm300682j |
| Homo sapiens | Type-1 angiotensin II receptor | Ki | 1.1 | nM | 10.1021/jm020138n |
| Homo sapiens | Type-1 angiotensin II receptor | Ki | 2.0 | nM | 10.1021/jm010457z |
| Homo sapiens | Type-1 angiotensin II receptor | Ki | 2.0 | nM | 10.1021/jm9904147 |
| Homo sapiens | Type-1 angiotensin II receptor | %Max (Mean) | 0.5895 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | pKa | 4.7 | None | 10.1021/jm049024x |
| Homo sapiens | Type-1 angiotensin II receptor | Ratio IC50 | 10.0 | None | 10.1016/j.bmc.2010.10.043 |
| Homo sapiens | Type-1 angiotensin II receptor | TIME | 0.15 | hr | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | TIME | 0.1667 | hr | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | TIME | 0.2833 | hr | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | TIME | 0.4167 | hr | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Type-1 angiotensin II receptor | TIME | 0.4333 | hr | 10.1016/j.bmcl.2017.06.051 |
| Homo sapiens | Tyrosine-protein kinase ABL | Delta TM | 0.06 | C | None |
| Homo sapiens | Tyrosine-protein kinase FYN | IC50 | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase FYN | Ki | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase LCK | IC50 | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase LCK | Ki | nan | None | None |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 8571.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 11828.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 14221.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 20657.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 20807.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 26450.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 31171.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 44507.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Growth Rate | -1.0 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.3 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.72 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.87 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.92 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.94 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.95 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.97 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 57.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 70.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 89.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 91.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 100.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 73.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 82.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 44.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 95.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 99.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 100.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 77.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 80.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 100.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 124.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 135.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 142.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 175.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 185.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 198.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 200.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 233.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 241.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 254.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 301.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 357.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 419.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Vascular endothelial growth factor receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Vascular endothelial growth factor receptor 1 | Ki | nan | None | None |
| Homo sapiens | Vasoactive intestinal polypeptide receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Vasoactive intestinal polypeptide receptor 1 | Ki | nan | None | None |
| Homo sapiens | Vasopressin V1a receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Vasopressin V1a receptor | IC50 | nan | None | None |
| Homo sapiens | Vasopressin V1a receptor | Ki | nan | None | None |
| Homo sapiens | Vasopressin V2 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | 7.4 | % | 10.6019/CHEMBL4513141 |
| Mus musculus | Nitric oxide synthase, inducible | IC50 | nan | None | None |
| Mus musculus | Nitric oxide synthase, inducible | Ki | nan | None | None |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | IC50 | nan | None | None |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | Ki | nan | None | None |
| Oryctolagus cuniculus | Arachidonate 15-lipoxygenase | IC50 | nan | None | None |
| Oryctolagus cuniculus | Arachidonate 15-lipoxygenase | Ki | nan | None | None |
| Oryctolagus cuniculus | Oryctolagus cuniculus | IC50 | 4.0 | nM | 10.1016/S0960-894X(01)81120-3 |
| Oryctolagus cuniculus | Oryctolagus cuniculus | IC50 | 4.0 | nM | 10.1021/jm00074a018 |
| Oryctolagus cuniculus | Oryctolagus cuniculus | IC50 | 4.0 | nM | 10.1021/jm9504722 |
| Photinus pyralis | Luciferin 4-monooxygenase | Potency | 19011.5 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 7568.6 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 13459.1 | nM | None |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | 1.45 | % | 10.6019/CHEMBL4513141 |
| Rattus norvegicus | Aldose reductase | IC50 | nan | None | None |
| Rattus norvegicus | Aldose reductase | Ki | nan | None | None |
| Rattus norvegicus | Alpha-1a adrenergic receptor | IC50 | nan | None | None |
| Rattus norvegicus | Alpha-1a adrenergic receptor | Ki | nan | None | None |
| Rattus norvegicus | Alpha-1b adrenergic receptor | IC50 | nan | None | None |
| Rattus norvegicus | Alpha-1b adrenergic receptor | Ki | nan | None | None |
| Rattus norvegicus | Androgen Receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Androgen Receptor | IC50 | nan | None | None |
| Rattus norvegicus | Androgen Receptor | Ki | nan | None | None |
| Rattus norvegicus | Angiotensin II receptor | IC50 | 1.3 | nM | 10.1016/S0960-894X(00)80286-3 |
| Rattus norvegicus | Angiotensin II receptor (AT-1) type-1 | Activity | 13500.0 | AUC units | 10.1021/jm049548x |
| Rattus norvegicus | Angiotensin II receptor (AT-1) type-1 | IC50 | 1.3 | nM | 10.1016/S0960-894X(01)81120-3 |
| Rattus norvegicus | Angiotensin II receptor (AT-1) type-1 | IC50 | 1.3 | nM | 10.1021/jm9504722 |
| Rattus norvegicus | Cyclooxygenase-1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Endothelin receptor ET-A | Activity | nan | None | 10.1021/jm049548x |
| Rattus norvegicus | GABA receptor alpha-1 subunit | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Glycine receptor | IC50 | nan | None | None |
| Rattus norvegicus | Glycine receptor | Ki | nan | None | None |
| Rattus norvegicus | Insulin receptor | IC50 | nan | None | None |
| Rattus norvegicus | Insulin receptor | Ki | nan | None | None |
| Rattus norvegicus | Liver | IC50 | nan | None | 10.1002/hep.27206 |
| Rattus norvegicus | Nitric-oxide synthase, brain | IC50 | nan | None | None |
| Rattus norvegicus | Nitric-oxide synthase, brain | Ki | nan | None | None |
| Rattus norvegicus | Rattus norvegicus | Activity | 20.0 | mmHg | 10.1039/C5MD00169B |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1016/j.bmc.2012.02.003 |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1021/jm020138n |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1039/C4MD00499J |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1039/C5MD00169B |
| Rattus norvegicus | Rattus norvegicus | ALB | 42000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 42300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 43300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 44700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 46500.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 46700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 278.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 299.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 300.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 305.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 316.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 366.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 42.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 44.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 44.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 46.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 49.17 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AOC | 11900.0 | None | 10.1016/s0960-894x(03)00018-0 |
| Rattus norvegicus | Rattus norvegicus | AST | 74.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 75.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 75.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 80.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 86.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 87.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASOLE | 0.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASOLE | 0.17 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASOLE | 0.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASOLE | 1.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 0.833 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BP | 84.0 | % | 10.1016/s0960-894x(03)00018-0 |
| Rattus norvegicus | Rattus norvegicus | BUN | 155.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 170.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 176.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 183.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 186.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 98.33 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 99.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 101.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 102.83 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 103.33 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 693.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 706.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 730.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 740.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 745.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 783.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 216.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 219.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 271.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 320.83 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 600.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 891.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 20000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 21330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 21500000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 24170000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 24330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 28330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 2.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 3.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 3.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | Delta MAP | 17.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Rattus norvegicus | Rattus norvegicus | Delta MAP | 18.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Rattus norvegicus | Rattus norvegicus | Delta MAP | 20.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Rattus norvegicus | Rattus norvegicus | Delta MAP | 22.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Rattus norvegicus | Rattus norvegicus | Delta MAP | 45.0 | mmHg | 10.1016/S0960-894X(01)81139-2 |
| Rattus norvegicus | Rattus norvegicus | ED30 | 0.16 | mg kg-1 | 10.1016/S0960-894X(01)80526-6 |
| Rattus norvegicus | Rattus norvegicus | ED50 | 0.3 | umol.kg-1 | 10.1021/jm020138n |
| Rattus norvegicus | Rattus norvegicus | ED50 | 16.0 | umol.kg-1 | 10.1021/jm020138n |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.83 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 1.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1333.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1360.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1396.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1408.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1440.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1620.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 42.37 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 43.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 43.12 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 43.13 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 43.7 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 44.8 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 141800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 142300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 146000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 146300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 147300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 149000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 161.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 197.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 210.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 289.83 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 300.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 345.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 8.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 8.83 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 9.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 9.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 72.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 75.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 75.17 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 79.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 80.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 81.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 19.6 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 20.17 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 20.25 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 20.3 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 20.33 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 20.35 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 329500.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 332000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 335700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 337300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 339500.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 59.0 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 59.7 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 59.8 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 59.93 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 60.47 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 61.43 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 1.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.83 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NE | nan | None | 10.1021/jm020138n |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 14.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 17.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 17.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 21.17 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 22.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 24.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 78.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 86.5 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 90.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 91.2 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 93.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 95.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1028500.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1093170.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1118000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1173330.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1218500.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1226330.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.55 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.6 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.65 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.67 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.95 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 61000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 61700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 63000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 63300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 66700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 67500.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 7010000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 7020000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 7200000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 7310000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 7590000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 138.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 139.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 142.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 144.17 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 145.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 146.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | TIME | 1.0 | hr | 10.1039/C5MD00169B |
| Rattus norvegicus | Rattus norvegicus | TIME | 3.0 | hr | 10.1016/j.bmc.2012.02.003 |
| Rattus norvegicus | Rattus norvegicus | URATE | 9.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 9.8 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 10.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 11.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 12.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 13.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 9050.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 9550.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 9630.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 11100.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 11400.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 11500.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | IC50 | nan | None | None |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Ki | nan | None | None |
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | IC50 | nan | None | None |
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | Ki | nan | None | None |
| Rattus norvegicus | Type-1A angiotensin II receptor | IC50 | 0.9 | nM | 10.1016/S0960-894X(01)80526-6 |
| Rattus norvegicus | Type-1B angiotensin II receptor | IC50 | 1.3 | nM | 10.1016/S0960-894X(01)81139-2 |
| Rattus norvegicus | Type-1B angiotensin II receptor | IC50 | 1.3 | nM | 10.1021/jm00074a018 |
| Rattus norvegicus | Type-1B angiotensin II receptor | Ki | 0.8 | nM | 10.1021/jm020138n |
| Rattus norvegicus | Voltage-gated L-type calcium channel alpha-1C subunit | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Voltage-gated N-type calcium channel alpha-1B subunit | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 9.227 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 13.92 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Hit score | 0.2008 | None | 10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -3.98 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.15 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.11 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition index | 0.3537 | None | 10.1101/2020.04.03.023846 |
| Staphylococcus aureus | Staphylococcus aureus | Inhibition | 6.34 | % | 10.6019/CHEMBL4513141 |
| Trypanosoma cruzi | Cruzipain | Potency | 39810.7 | nM | None |
| None | ADMET | Activity | 300.0 | mg | 10.1021/acs.jmedchem.0c00524 |
| None | ADMET | Biotransformation | nan | None | 10.1038/s41586-019-1291-3 |
| None | ADMET | CL | 2.1 | mL.min-1.kg-1 | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | CL | 2.3 | mL.min-1.kg-1 | 10.1124/dmd.108.020479 |
| None | ADMET | CL | 9.01 | uL.min-1.(10^6cells)-1 | 10.6019/CHEMBL3301361 |
| None | ADMET | CL | 10.47 | uL.min-1.(10^6cells)-1 | 10.6019/CHEMBL3301361 |
| None | ADMET | CL | 12.1 | mL.min-1.kg-1 | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | CL | 17.78 | mL.min-1.g-1 | 10.6019/CHEMBL3301361 |
| None | ADMET | CL | 39.0 | mL.min-1.kg-1 | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | CL_renal | 0.02 | ml s-1 | 10.1021/jm0204237 |
| None | ADMET | CLtotal | 5.1 | ml s-1 | 10.1021/jm0204237 |
| None | ADMET | F | 70.0 | % | 10.1021/jm049024x |
| None | ADMET | F | 90.0 | % | 10.1021/jm990412m |
| None | ADMET | Fu | 0.000126 | None | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | Fu | 0.000155 | None | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | Modification of adsorbed drug | 20.0 | % | 10.1021/jm049024x |
| None | ADMET | MRT | 6.8 | hr | 10.1124/dmd.108.020479 |
| None | ADMET | Papp | 8.6 | 10^-6 cm/s | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | pKa | 4.7 | None | 10.1021/jm0204237 |
| None | ADMET | PPB | 98.54 | % | 10.6019/CHEMBL3301361 |
| None | ADMET | Ratio | 0.55 | None | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | Ratio | 0.603 | None | 10.1021/acs.jmedchem.0c01033 |
| None | ADMET | T1/2 | 10.0 | hr | 10.1021/jm0204237 |
| None | ADMET | T1/2 | 14.0 | hr | 10.1124/dmd.108.020479 |
| None | ADMET | T1/2 | 21.0 | hr | 10.1021/jm049024x |
| None | ADMET | Vd | 0.9 | L.kg-1 | 10.1021/jm049024x |
| None | ADMET | Vdss | 0.94 | L.kg-1 | 10.1124/dmd.108.020479 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx1000865 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx900326k |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1124/dmd.110.035113 |
| None | Hepatotoxicity | HepSE_bilirubinemia | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholecystitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholelithiasis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cirrhosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_Combined Scores | 3.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_elevated liver function tests | 1.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic failure | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic necrosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatitis | 1.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatomegaly | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_jaundice | 1.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver disease | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver fatty | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver function tests abnormal | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | NON-PROTEIN TARGET | Activity | nan | None | 10.1016/j.ejmech.2016.07.023 |
| None | NON-PROTEIN TARGET | Fu | 0.1 | None | 10.1124/dmd.108.020479 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (acute) | 0.0 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (animal toxicity known) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (benign tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (granulomatous hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (mechanism) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 2.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 4.3 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (time to onset) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | No relevant target | LogD | 0.9 | None | 10.1016/j.bmcl.2011.04.133 |
| None | No relevant target | LogD | 1.3 | None | 10.1021/acs.jmedchem.0c01033 |
| None | No relevant target | LogD | 2.4 | None | 10.1016/j.bmcl.2011.04.133 |
| None | No relevant target | LogD7.4 | 1.29 | None | 10.6019/CHEMBL3301361 |
| None | No relevant target | pKa | 3.5 | None | 10.1021/acs.jmedchem.0c01033 |
| None | No relevant target | pKa | 4.6 | None | 10.1021/acs.jmedchem.0c01033 |
| None | No relevant target | pKa_A1 | 3.91 | None | 10.6019/CHEMBL3301361 |
| None | No relevant target | pKa_B1 | nan | None | 10.6019/CHEMBL3301361 |
| None | No relevant target | Solubility | 891300.0 | nM | 10.6019/CHEMBL3301361 |
| None | Unchecked | Ac50 | 0.631 | uM | None |
| None | Unchecked | Ac50 | 2.818 | uM | None |
| None | Unchecked | Ac50 | 6.31 | uM | None |
| None | Unchecked | Ac50 | 39.81 | uM | None |
| None | Unchecked | AC50 | 631.0 | nM | None |
| None | Unchecked | AC50 | 2820.0 | nM | None |
| None | Unchecked | AC50 | 6309.6 | nM | None |
| None | Unchecked | AC50 | 39810.7 | nM | None |
| None | Unchecked | Activity | 31.0 | % | 10.1016/j.ejmech.2020.112258 |
| None | Unchecked | Activity | 38.0 | % | 10.1021/acs.jmedchem.0c00262 |
| None | Unchecked | Activity | nan | None | 10.1016/j.ejmech.2020.112258 |
| None | Unchecked | Hepatotoxicity (acute) | 2.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (association with vascular disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (choleostasis) | 2.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (chronic liver disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cirrhosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (comment) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cytolytic) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (malignant tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (severe hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (steatosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (successful reintroduction) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | IC50 | 0.58 | nM | 10.1016/j.bmc.2012.02.003 |
| None | Unchecked | IC50 | 1.3 | nM | 10.1016/j.bmc.2010.10.043 |
| None | Unchecked | IC50 | 1.46 | nM | 10.1016/j.ejmech.2016.07.023 |
| None | Unchecked | IC50 | 3.11 | nM | 10.1016/j.bmc.2012.09.065 |
| None | Unchecked | IC50 | 4.0 | nM | 10.1021/jm010457z |
| None | Unchecked | IC50 | nan | None | None |
| None | Unchecked | Inhibition | nan | % | 10.1016/j.bmc.2012.02.003 |
| None | Unchecked | Inhibition | nan | % | 10.1016/j.bmc.2012.09.065 |
| None | Unchecked | Ki | 0.41 | nM | 10.1016/j.bmc.2012.02.003 |
| None | Unchecked | Ki | 1.05 | nM | 10.1016/j.ejmech.2016.07.023 |
| None | Unchecked | Ki | 2.75 | nM | 10.1016/j.bmc.2012.09.065 |
| None | Unchecked | Ki | nan | None | None |
| None | Unchecked | Ratio | 0.026 | None | 10.1093/toxsci/kft176 |
| None | Unchecked | Ratio | 0.104 | None | 10.1093/toxsci/kft176 |
| None | Unchecked | Ratio | 0.301 | None | 10.1093/toxsci/kft176 |
